Amgen Cuts Cholesterol Drug’s Price 60% After Weak Sales

(Bloomberg) -- Amgen Inc. plans to cut the cost of its marquee cholesterol fighter after many patients struggled to afford it, and as drugmakers face increased scrutiny of their pricing practices.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.